Skip to main content
Sabina Signoretti, MD, Medical Genetics, Boston, MA

SabinaSignorettiMD

Medical Genetics Boston, MA

Clinical Molecular Genetics

Physician

Dr. Signoretti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Signoretti's full profile

Already have an account?

  • Office

    75 Francis St
    Boston, MA 02115
    Phone+1 617-525-7437
    Fax+1 617-264-5169

Summary

  • Sabina Signoretti, MD, is based in Boston, MA, and specializes in Medical Genetics with a focus on Clinical Molecular Genetics. She is a Professor at Brigham and Women's Hospital. Dr. Signoretti graduated in 1988 from Sapienza University of Rome. Her recent publications include research on immunogenomic predictors of outcomes in renal cell carcinoma, spatial multi-omics integration linked to response to immunotherapy, and predictive biomarkers for targeted therapies in renal cell carcinoma. Her work often appears in esteemed journals such as Nature Cancer, Clinical Cancer Research and Nature Medicine among others.

Education & Training

  • Sapienza University of Rome
    Sapienza University of RomeClass of 1988

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2017 - 2025
  • Clinical Molecular Genetics and Genomics
    American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Publications & Presentations

PubMed

Journal Articles

  • Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid Tumors  
    Jeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature

Press Mentions

  • Study Reveals Factors Influencing Outcomes in Kidney Cancer Treated with Immunotherapy
    Study Reveals Factors Influencing Outcomes in Kidney Cancer Treated with ImmunotherapyMay 29th, 2020

Grant Support

  • Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinomaDANA-FARBER CANCER INST2022–2027